Cbd Unlimited Mistx Topical Analgesic
NDC Package 73045-002-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Cbd Unlimited Mistx Topical Analgesic is adults and children 12 years of age & older. Marketed by Endexx Corporation, this product is identified by NDC 73045-002 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
73045-002-30
Package Description
30 mL in 1 BOTTLE, SPRAY
Product Code
73045-002
11-Digit Billing Format
73045000230

Clinical Specifications

Proprietary Name
Cbd Unlimited Mistx Topical Analgesic
Dosage Form
-
Usage Information
Adults and children 12 years of age & older. Spray a thin flim over affected area not more than 3 to 4 times daily: massage not necessary, for children 12 years or younger, consult a doctor.

Regulatory & Marketing

Labeler Name
Endexx Corporation
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
04-12-2019
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73045-002-30 identifies a specific commercial package of 30 ml in 1 bottle, spray of Cbd Unlimited Mistx Topical Analgesic, labeled by Endexx Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Endexx Corporation on April 12, 2019. The current certification is valid through December 31, 2022.

How is this Endexx Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73045000230. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73045-002-30
11-Digit CMS (5-4-2)
73045-0002-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.